Optimizing Antibiotic Use in India: Addressing Challenges and Exploring Opportunities

Vineela Hasiny R

doi:10.37022/tjmdr.v6i2.967

R. Vineela Hasiny Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, Annamacharya University, Andhra Pradesh, India

DOI https://doi.org/10.37022/tjmdr.v6i2.967

Abstract

Prosopagnosia, commonly known as face blindness, is a neurological condition characterized by a marked inability to recognize familiar faces, and in some cases, even one's own face. Historically considered a rare disorder primarily associated with acquired brain injury, the recognition of developmental prosopagnosia as a common condition has renewed scientific interest in the disorder. This review provides a comprehensive overview of the current understanding of prosopagnosia, with particular emphasis on its prevalence, diagnosis, genetic basis, and potential therapeutic approaches. Subjective and objective diagnostic measures, including the Cambridge Face Memory Test (CFMT) and the Prosopagnosia Index (PI20), are discussed. Developmental prosopagnosia is estimated to affect more than 2% of the general population, highlighting the importance of increased awareness and accurate diagnosis. The review also examines the substantial genetic contribution to developmental prosopagnosia, including evidence for high heritability, while considering the potential influence of environmental factors. Currently, there is no established standard treatment, and management primarily relies on compensatory strategies to help individuals cope with difficulties in face recognition. Nevertheless, emerging research offers promising future directions, including the potential use of neuromodulatory agents such as oxytocin, advances in genetic research and neuroimaging, and targeted cognitive training. Overall, this review summarizes current knowledge of prosopagnosia and identifies important avenues for future research aimed at improving diagnosis, understanding underlying mechanisms, and developing effective interventions and support strategies for individuals affected by face blindness.

Keywords: Prosopagnosia, Face Blindness, Developmental Prosopagnosia, Cambridge Face Memory Test, PI20, Genetics, Oxytocin, Diagnosis

References

1. Bodamer, J. (1947). Die Prosop-Agnosie. Archiv für Psychiatrie und Nervenkrankheiten, 179(1-2), 6-53. [Note: This is the foundational historical paper, available in German. English summaries and its impact are widely cited, e.g., in reference 2].
2. Barton, J. J. S. (2008). Structure and function in acquired prosopagnosia: a review of the neuropsychological and MRI literature. Cortex, 44(8), 933-948.
3. [McConachie, H. R. (1976). Developmental prosopagnosia. A single case report. Cortex, 12(1), 76-82.
4. Kennerknecht, I., Grueter, T., Welling, B., Wentzek, S., Horst, J., Edwards, S., & Grueter, M. (2006). First report of prevalence of non-syndromic hereditary prosopagnosia (HPA). American Journal of Medical Genetics Part A, 140(15), 1617-1622.
5. Bowles, D. C., McKone, E., Dawel, A., Duchaine, B., Palermo, R., Schmalzl, L., ... & Yovel, G. (2009). Diagnosing prosopagnosia: Effects of theory and test choice. Cortex, 45(6), 758-774.
6. Dalrymple, K. A., & Palermo, R. (2016). The impact of prosopagnosia on daily life: A qualitative study of the experiences of adults with developmental and acquired prosopagnosia. British Journal of Psychology, 107(1), 1-21.
7. Shah, P., Gaule, A., Sowden, S., Bird, G., & Cook, R. (2015). The 20-item Prosopagnosia Index (PI20): A self-report instrument for identifying developmental prosopagnosia. Royal Society Open Science, 2(6), 140344.
8. Duchaine, B., & Nakayama, K. (2006). The Cambridge Face Memory Test: Results for neurologically intact individuals and an investigation of its validity using inverted face stimuli and prosopagnosic participants. Neuropsychologia, 44(4), 576-5815.
9. Duchaine, B., Yovel, G., & Nakayama, K. (2007). The Cambridge Face Perception Test: a new test of face perception. Journal of Vision, 7(9), 984-984.
10. Towler, J., Fisher, K., & Eimer, M. (2017). The cognitive and neural basis of developmental prosopagnosia. The Quarterly Journal of Experimental Psychology, 70(2), 316-344.
11. Grueter, M., Grueter, T., Bell, V., Horst, J., Laskowski, W., Sperling, K., ... & Kennerknecht, I. (2007). Hereditary prosopagnosia: the first case series. Cortex, 43(6), 734-749.
12. Wilmer, J. B., Germine, L., Chabris, C. F., Chatterjee, G., Williams, M., Loken, E., ... & Nakayama, K. (2010). Human face recognition is specific and highly heritable. Proceedings of the National Academy of Sciences, 107(11), 5238-5241.
13. Le Grand, R., Mondloch, C. J., Maurer, D., & Brent, H. P. (2001). Early visual experience and face processing. Nature, 410(6831), 890-890.
14. Bate, S., Cook, S. J., Duchaine, B., Tree, J. J., & Burns, E. J. (2014). Intranasal oxytocin modulates face processing in developmental prosopagnosia. Neuropsychologia, 54, 80-86.
15. Domes, G., Heinrichs, M., Kumbier, E., &Herpertz, S. C. (2013). Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder. Biological Psychiatry, 74(3), 164-171.
16. Thomas, C., Avidan, G., Humphreys, K., Jung, K. J., Gao, F., & Behrmann, M. (2009). Reduced structural connectivity in ventral visual cortex in congenital prosopagnosia. Nature Neuroscience, 12(1), 29-31.
17. DeGutis, J., Bentin, S., Robertson, L. C., & D'Esposito, M. (2007). Functional plasticity in ventral temporal cortex following cognitive rehabilitation of a congenital prosopagnosic. Journal of Cognitive Neuroscience, 19(11), 1790-1802.